LV11940A - Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas - Google Patents

Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas

Info

Publication number
LV11940A
LV11940A LV970144A LV970144A LV11940A LV 11940 A LV11940 A LV 11940A LV 970144 A LV970144 A LV 970144A LV 970144 A LV970144 A LV 970144A LV 11940 A LV11940 A LV 11940A
Authority
LV
Latvia
Prior art keywords
melatonin
grass
dependent
people
treatment
Prior art date
Application number
LV970144A
Other languages
English (en)
Other versions
LV11940B (lv
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of LV11940A publication Critical patent/LV11940A/lv
Publication of LV11940B publication Critical patent/LV11940B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LVP-97-144A 1995-02-01 1997-07-24 Melatonīna pielietojums personu ārstēšanai, kuras cieš no zāļu atkarības LV11940B (lv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
LV11940A true LV11940A (lv) 1998-01-20
LV11940B LV11940B (lv) 1998-05-20

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-144A LV11940B (lv) 1995-02-01 1997-07-24 Melatonīna pielietojums personu ārstēšanai, kuras cieš no zāļu atkarības

Country Status (22)

Country Link
JP (1) JP4516159B2 (lv)
CN (1) CN1083263C (lv)
AT (1) AT408188B (lv)
AU (1) AU695366B2 (lv)
BG (1) BG62876B1 (lv)
BR (1) BR9607169A (lv)
CZ (1) CZ291349B6 (lv)
DK (1) DK176081B1 (lv)
EE (1) EE03384B1 (lv)
FI (1) FI119586B (lv)
IS (1) IS1980B (lv)
LU (1) LU90118B1 (lv)
LV (1) LV11940B (lv)
MD (1) MD1716C2 (lv)
NO (1) NO312814B1 (lv)
NZ (1) NZ298878A (lv)
PL (1) PL183148B1 (lv)
SI (1) SI9620022A (lv)
SK (1) SK284521B6 (lv)
TR (1) TR199700723T1 (lv)
TW (1) TW483757B (lv)
WO (1) WO1996023496A1 (lv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200379A (et) 2000-01-05 2003-10-15 Neurim Pharmaceuticals (1991) Ltd. Meetod ja preparaat antihüpertensiivsete ainete suhtes resistentsuse ja sellega seotud haigusseisundite raviks
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
KR102593047B1 (ko) 2012-01-26 2023-10-24 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
CA2893542C (en) 2012-12-18 2022-07-19 Vanda Pharmaceuticals Inc. Use of tasimelteon in the treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
ES2828034T3 (es) * 2016-10-31 2021-05-25 Neurim Pharma 1991 Minicomprimidos de melatonina y método de fabricación de los mismos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229490T2 (de) * 1991-05-09 2000-02-17 Neurim Pharma 1991 Melatonin enthaltende Arzneimittel
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
DK176081B1 (da) 2006-04-18
NO973531D0 (no) 1997-07-31
IS1980B (is) 2005-01-14
BR9607169A (pt) 1997-11-11
MD1716C2 (ro) 2002-02-28
FI973185A (fi) 1997-09-30
EE03384B1 (et) 2001-04-16
CZ291349B6 (cs) 2003-02-12
DK89697A (da) 1997-07-30
SK103097A3 (en) 1998-01-14
PL321630A1 (en) 1997-12-08
TW483757B (en) 2002-04-21
TR199700723T1 (xx) 1998-02-21
JPH10513177A (ja) 1998-12-15
AU695366B2 (en) 1998-08-13
JP4516159B2 (ja) 2010-08-04
NO312814B1 (no) 2002-07-08
BG62876B1 (bg) 2000-10-31
IS4532A (is) 1997-07-25
AU4457496A (en) 1996-08-21
NZ298878A (en) 1999-05-28
EE9700166A (et) 1998-02-16
CZ240597A3 (cs) 1998-01-14
NO973531L (no) 1997-09-30
MD1716B2 (en) 2001-08-31
MD970254A (en) 1999-05-31
CN1172431A (zh) 1998-02-04
FI119586B (fi) 2009-01-15
ATA901396A (de) 2001-02-15
MX9705856A (es) 1998-07-31
FI973185A0 (fi) 1997-07-31
BG101803A (en) 1998-04-30
AT408188B (de) 2001-09-25
WO1996023496A1 (en) 1996-08-08
LU90118B1 (fr) 1997-11-13
LV11940B (lv) 1998-05-20
SK284521B6 (sk) 2005-05-05
SI9620022A (sl) 1998-10-31
CN1083263C (zh) 2002-04-24
PL183148B1 (pl) 2002-05-31

Similar Documents

Publication Publication Date Title
NO991381L (no) Kombinasjonsterapi for behandling av psykoser
FI952926A0 (fi) Menetelmät allergioiden hoitamiseksi tai ehkäisemiMenetelmät allergioiden hoitamiseksi tai ehkäisemiseksi seksi
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DE69600307D1 (de) Beatmungsgerät zur Behandlung von Ateminsuffizienzen
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
DK19893D0 (da) Praeparat til nasal behandling
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
LV11940A (lv) Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas
NO983512D0 (no) Midler for behandling og forhindring av AIDS
ATE347372T1 (de) Vakzine zur behandlung von mycosen
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
DE69604071D1 (de) Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO994258L (no) Anvendelse av levobupivakain for behandling av ansiktsmigrene
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO974529D0 (no) Innretning for tilförselen av alfuzosin gjennom huden
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO982562D0 (no) Sammensetning for behandling av smerte
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS